Negative Pressure Wound Tx No Benefit for Lower Limb Open Fx

Share this content:
Negative Pressure Wound Tx No Benefit for Lower Limb Open Fx
Negative Pressure Wound Tx No Benefit for Lower Limb Open Fx

WEDNESDAY, June 13, 2018 (HealthDay News) -- Use of a negative pressure wound therapy (NPWT) for severe open fracture of the lower limb is not associated with improved self-rated disability at 12 months, compared with standard wound dressing, according to a study published in the June 12 issue of the Journal of the American Medical Association.

Matthew L. Costa, Ph.D., from the University of Warwick in the United Kingdom, and colleagues recruited patients aged 16 years or older with a severe open fracture of the lower limb. Participants were randomized to receive NPWT (226 patients) or standard dressings not involving application of negative pressure (234 patients).

The researchers observed no statistically significant between-group differences in the patients' Disability Rating Index score at 12 months (mean score, 45.5 and 42.4 in the NPWT and standard dressing groups, respectively; mean difference, −3.9; 95 percent confidence interval [CI], −8.9 to 1.2; P = 0.13); in terms of the number of deep surgical site infections (7.1 and 8.1 percent, respectively; difference, 1.0 percent; 95 percent CI, −4.2 to 6.3 percent; P = 0.64); or in quality of life as measured by the difference in EuroQoL 5-dimensions questionnaire (0.02; 95 percent CI, −0.05 to 0.08). There were also no statistically significant differences noted in the Short Form-12 Physical Component Score (0.5; 95 percent CI, −3.1 to 4.1) and the Short Form-12 Mental Health Component Score (−0.4; 95 percent CI, −2.2 to 1.4).

"The findings do not support this treatment for severe open fractures," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »